Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Henry Schein Named To FORTUNE's List Of Most Admired Companies For 12th Consecutive Year

Stock quotes in this article: HSIC 

MELVILLE, N.Y., March 6, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, has been named to the 2013 FORTUNE list of the "World's Most Admired Companies". Henry Schein has been a FORTUNE "Most Admired" company for 12 consecutive years. For 2013, Henry Schein earned first-place rankings within its industry in five of nine categories, including Social Responsibility, Global Competitiveness, Quality of Management, Quality of Products/Services and Use of Corporate Assets.  Henry Schein ranked second among other industry companies in the four remaining categories (Innovation, People Management, Long-Term Investment and Financial Soundness). 

"It is gratifying to again be recognized within our industry as one of the 'World's Most Admired Companies'," said Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc.  "In particular, we are very pleased to have once again been ranked first in our industry for Social Responsibility – a result of our global Henry Schein Cares initiatives – as well as first for Global Competitiveness.  By continuing to set the industry standard for these two pillars of corporate performance, we believe that we are demonstrating the wisdom of Benjamin Franklin's philosophy of 'enlightened self interest.'  Henry Schein is proving that it is possible to 'do well by doing good,' and that being a responsible corporate citizen is good business."   

Henry Schein Cares, the Company's global corporate social responsibility program, helps increase access to care for underserved populations globally through three focus areas:  wellness, prevention, and treatment; emergency preparedness and relief; and health care capacity building. 

Henry Schein's global competitiveness is fueled by the Company's operations or affiliates in 25 countries around the world.  Henry Schein's sales outside of the United States represented 39 percent of total Company sales in 2012.  

For more information on Fortune's 2013 "World's Most Admired Companies" rankings, please visit http://money.cnn.com/magazines/fortune/most-admired/2013/list/.

About Henry Schein, Inc.

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners.  The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.  A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 15,000 Team Schein Members and serves more than 775,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries.  The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17 percent since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein Web site at www.henryschein.com.

SOURCE Henry Schein, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs